These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15529271)

  • 1. Quantification of human immunodeficiency virus type 1 by reverse transcriptase-coupled polymerase chain reaction.
    Kuritzkes DR
    J Infect Dis; 2004 Dec; 190(11):2047-54. PubMed ID: 15529271
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevation of viral load by PCR and use of plasma preparation tubes for quantification of human immunodeficiency virus type 1.
    García-Bujalance S; Ladrón de Guevara C; González-García J; Arribas JR; Zamora F; Gutiérrez A
    J Microbiol Methods; 2007 May; 69(2):384-6. PubMed ID: 17363096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodeficiency viruses. 1959 and all that.
    Wain-Hobson S
    Nature; 1998 Feb; 391(6667):531-2. PubMed ID: 9468129
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV-1 viral load in blood and semen plasma of Brazilian patients under antiretroviral therapy.
    Medeiros RP; Munerato P; Diaz RS
    J Clin Virol; 2004 Aug; 30(4):346-7. PubMed ID: 15163426
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the LCx human immunodeficiency virus (HIV) RNA quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan assays for quantitation of HIV type 1 RNA in plasma.
    Foulongne V; Montes B; Didelot-Rousseau MN; Segondy M
    J Clin Microbiol; 2006 Aug; 44(8):2963-6. PubMed ID: 16891517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-class-resistant human immunodeficiency virus type 1 variant in a drug-naive heterosexual couple.
    Razzolini F; Saladini F; Malincarne L; Vicenti I; Palladino N; Romano L; Francisci D; Zazzi M
    J Clin Microbiol; 2008 Nov; 46(11):3856-9. PubMed ID: 18845824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care industries' perspective of viral load assays: the VERSANT HIV-1 RNA 3.0 assay.
    Elbeik T; Loftus RA; Beringer S
    Expert Rev Mol Diagn; 2002 May; 2(3):275-85. PubMed ID: 12050866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 3 nucleic acid isolation methods for the quantification of HIV-1 RNA by Cobas Taqman real-time polymerase chain reaction system.
    Alp A; Hascelik G
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):365-71. PubMed ID: 19232859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantification of HIV-1 viral load by the measurement of reverse transcriptase activity].
    García Lerma JG; Heneine W
    Med Clin (Barc); 1998 Apr; 110(12):453-4. PubMed ID: 9611714
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic tests: Human immunodeficiency virus type 1, type 2 (HIV-1, HIV 2)].
    Fujii T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():434-7. PubMed ID: 16111295
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression.
    Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J
    Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 load quantitation: a 17-year perspective.
    Holodniy M
    J Infect Dis; 2006 Sep; 194 Suppl 1():S38-44. PubMed ID: 16921471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The measurement of HIV-1 viral load in resource-limited settings: how and where?
    Rouet F; Rouzioux C
    Clin Lab; 2007; 53(3-4):135-48. PubMed ID: 17447649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty years of therapy for HIV-1 infection.
    Pomerantz RJ; Horn DL
    Nat Med; 2003 Jul; 9(7):867-73. PubMed ID: 12835707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
    Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
    J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral resistance.
    Geretti AM
    J HIV Ther; 2006 Dec; 11(4):72-3. PubMed ID: 17578209
    [No Abstract]   [Full Text] [Related]  

  • 19. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Questions about results reported with potent antiretroviral therapy for human immunodeficiency virus type 1 infection.
    Papadopulos-Eleopulos E; Turner VF; Papadimitriou JM; Alfonso H; Page B; Causer D
    J Infect Dis; 2000 Apr; 181(4):1518-20. PubMed ID: 10762589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.